- our experts
- Student Sphere
- Hotel & Travel
Neuropharmacology refers to the study of the effects of drugs on the nervous system, this field involve the study and research on the actions of medications for psychiatric and neurologic disorders as well as those of drugs of abuse. Neuropharmacology also uses drugs as tools for better understanding of normal nervous system functioning. The main objective of neuropharmacology is to apply mechanisms of drugs to develop effective treatments and preventive measures for nervous system abnormalities. It helps to understand how drugs affect cellular function in the nervous system. Behavioral and molecular are the two different parts of neuropharmacology . Behavioral neuropharmacology focuses on the study of how drugs affect human behavior and molecular neuropharmacology involves the study of neurons and their neurochemical interactions, with an aim of developing drugs that helps in improving neurological function.
The study of neurotransmitters, psychopharmaceuticals and neuropeptides, that control and influence the physiology of the nervous system is known as Neurochemistry. Research in this field is focused on the biochemistry and molecular biology of organic compounds in the nervous system, and their roles in neural processes like cortical plasticity, neurogenesis, and neural differentiation. Neurochemicals are basically oxytocin, serotonin, dopamine and other neurotransmitters and neurotransmitter-regulating substances. This particular field investigates how neurochemicals influence the operation of neurons, synapses, and neural networks.
Market Analysis: Pharmaceuticals are one of the most valuable endeavours on the planet. In 2008, the pharmaceutical industry sold $773 billion in goods around the world, a figure that has been consistent for up to 8 years and is expected to rise by 2.5 to 3.5 percent in 2017. By 2025, the global pharmaceutical market is expected to reach $10.27 billion USD. The pharmaceutical market is expected to grow from just over $22.85 billion in 2016 to $25.2 billion in 2020, with a compound annual growth rate (CAGR) of 2%. It is expected to reach USD 2,151.1 billion by 2027, growing at a CAGR of 7%.
ALSO READ Neurology Neurosurgery Neuroscience Neuropsychiatry Pain Disorder and Management Central Nervous System Pediatric Neurology Neuro-Oncology and Brain Tumors Neurophysiology Neuroimmunology Neuropathology Neuroimaging Neurodegenerative disease and Neurodegeneration Neurological Disorders Sleep Disorder Stroke Movement Disorders Parkinsons Disease Epilepsy Multiple Sclerosis Alzheimers Disease and Dementia Neuromuscular Disease Case Studies and Clinical Trials Novel Treatment Strategies Speech Disorders Demyelinating Disorders Cerebrovascular Disorders Autoimmune and Inflammatory Disorders Neuropathy Headache and Facial Pain Diagnosis and Screening of Neurological Disorders Neuropharmacology and Neurochemistry Stem Cells and Neuroregeneration Cognitive Neuroscience Motor System Disorders Behavioral Neurology Computational Neuroscience Neurogenetics Spinal Neurosurgery Pediatric Neurosurgery Stereotactic and Functional Neurosurgery Neurovascular Surgery Intraoperative Neurophysiology Peripheral Nerve Surgery Robotics in Neurosurgery Latest advancement in Brain Surgery Skull Base Surgery Trauma and Critical Care Child Psychology Social Cognitive Neuroscience Neurophysics Neuroradiology Neurorobotics
Neurology Conferences Europe Neurology Conferences USA Neurology Conferences 2022 Neurology Conferences 2022 Epilepsy Conferences Child Psychology Conferences Dementia Conferences Neurodegenerative Disorders Conferences Alzheimer's Disease Conferences CNS Conferences Neurology Conferences 2022 Asia Cerebrovascular Disease Conferences Psychiatry Conferences Euro Neurology Conferences Clinical Neurology Conferences